FTK FLOTEK INDUSTRIES INC/CN/
Miscellaneous Chemical Products · NYSE · SEC CIK 928054 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY59.3%
TTM net income YoY-3.1%
TTM EPS YoY-15.2%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR105.2%
Margins
Gross margin23.3%
Operating margin13.2%
Net margin8.8%
FCF margin—
EBITDA margin14.0%
Returns
ROE24.4%
ROA11.8%
ROIC (approx.)26.2%
Asset turnover1.34x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity0.00x
Current ratio2.30x
Interest coverage8.45x
Cash quality & payout
Operating cash flow / net income-0.34x
Accruals ratio15.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $114.35M | $99.37M | $70.05M | $67.52M | $56.03M | $58.35M | $55.36M | $50.76M |
| Cost of revenue | $86.96M | $75.58M | $54.51M | $52.33M | $38.25M | $43.94M | $42.91M | $38.48M |
| Gross profit | $27.39M | $23.78M | $15.54M | $15.19M | $17.78M | $14.41M | $12.45M | $12.28M |
| R&D expense | $473,000 | $497,000 | $396,000 | $463,000 | $549,000 | $455,000 | $355,000 | $365,000 |
| SG&A expense | $8.51M | $7.74M | $6.92M | $7.58M | $7.38M | $6.80M | $6.28M | $6.65M |
| Operating income | $17.95M | $14.89M | $7.59M | $5.99M | $9.10M | $2.59M | $5.57M | $5.14M |
| Interest expense | $1.42M | $1.37M | $1.33M | $1.37M | $1.35M | $983,000 | $229,000 | $253,000 |
| Pretax income | $16.35M | $13.53M | $6.27M | $4.68M | $7.74M | $1.78M | $5.44M | $4.79M |
| Income tax | $3.05M | $3.58M | $1.61M | $1.66M | -$12.61M | $17,000 | $64,000 | $356,000 |
| Net income | $13.31M | $9.95M | $4.66M | $3.02M | $20.36M | $1.77M | $5.38M | $4.43M |
| EBITDA | $18.62M | $15.55M | $8.22M | $6.62M | $9.68M | $2.96M | $5.82M | $5.37M |
| EPS (basic) | 0.37 | 0.28 | 0.13 | — | 0.57 | 0.05 | 0.18 | — |
| EPS (diluted) | 0.34 | 0.26 | 0.12 | — | 0.53 | 0.05 | 0.17 | — |
| Weighted avg. shares (diluted) | 38.68M | 38.47M | 38.34M | — | 38.14M | 36.23M | 31.75M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $21.27M | $4.40M | $5.68M | $5.73M | $4.60M | $5.03M | $6.25M | $4.40M |
| Inventory | $33.72M | $26.63M | $14.30M | $10.63M | $13.23M | $12.30M | $13.69M | $13.30M |
| Current assets | $213.12M | $167.54M | $125.79M | $110.78M | $100.02M | $86.83M | $97.35M | $96.46M |
| PP&E, net | $24.54M | $23.25M | $21.91M | $20.34M | $20.82M | $21.22M | $6.43M | $6.18M |
| Total assets | $311.11M | $268.04M | $231.84M | $220.05M | $212.69M | $172.24M | $170.24M | $170.80M |
| Current liabilities | $92.50M | $94.14M | $68.73M | $61.58M | $56.48M | $54.68M | $44.40M | $50.37M |
| Long-term debt | — | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | — | $0 |
| Total debt | — | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | — | $0 |
| Total liabilities | $167.59M | $138.82M | $113.67M | $106.99M | $102.19M | $100.39M | $50.53M | $56.90M |
| Shareholders' equity | $143.52M | $129.21M | $118.17M | $113.06M | $110.50M | $71.85M | $119.70M | $113.90M |
| Net debt | — | $35.60M | $34.32M | $34.27M | $35.40M | $34.97M | — | -$4.40M |
| Shares outstanding | 36.22M | 36.22M | 36.17M | 30.13M | 29.99M | 29.85M | 29.83M | 29.83M |
| Cash flow statement | ||||||||
| Operating cash flow | -$10.26M | -$6.60M | $21,000 | $6.25M | -$1.86M | -$4.49M | $7.31M | -$2.56M |
| Investing cash flow | -$463,000 | -$237,000 | -$1.00M | -$287,000 | -$388,000 | -$711,000 | -$591,000 | -$1.36M |
| Financing cash flow | $27.60M | $5.54M | $892,000 | -$4.82M | $1.81M | $4.09M | -$4.83M | $3.21M |
| Depreciation & amortization | $666,000 | $664,000 | $631,000 | $629,000 | $581,000 | $374,000 | $252,000 | $229,000 |
| Stock-based compensation | $987,000 | $1.21M | $824,000 | $594,000 | $569,000 | $676,000 | $461,000 | $451,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.